Clinical Trials on Nicotine Dependence in New Zealand

Total 331 results

Yale University

Completed

Switching to Potential Reduced Exposure Products in Adult Smokers (ZYN)

Tobacco Use Disorder | Carcinogenesis | Harm Reduction | Smoking Behaviors | Oral Nicotine Pouch Use | Toxic Effect of Tobacco and Nicotine

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Completed

Aprepitant Effects in Intravenous Heroin Dependence

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1

Heroin Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (NAMHS)

Heroin Dependence | Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States
National Development and Research Institutes, Inc.

Unknown

Applying Web Technology to Buprenorphine Treatment

Adult Opioid-Dependence

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1

Substance-Related Disorders | Heroin Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence

Opiate Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Nalrexone Facilitated Discontinuation of Buprenorphine

Stable Opioid Dependence

United States
State University of New York - Upstate Medical...
US Department of Veterans Affairs

Terminated

Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial

Alcohol Dependence | Veterans

United States
National Development and Research Institutes, Inc.
St. Luke's-Roosevelt Hospital Center

Unknown

Science-Based Treatment for Opioid-Dependent Adolescents

Opioid-Dependence Among Adolescents

United States
NYU Langone Health
Forest Laboratories

Completed

A Clinical Trial of Acamprosate for Treatment of Methamphetamine Addiction (AcampMet)

Methamphetamine Dependence, Treatment Seeking

United States
Yale University

Withdrawn

Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol).

Drug Dependence

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

A Placebo-Controlled Trial of Memantine for Alcohol Dependence

Alcohol Abuse | Alcohol Dependence (Primary Condition)

United States
GlaxoSmithKline

Withdrawn

Relapse Prevention Study in Newly Abstinent Smokers

Substance Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients

Benzodiazepine Dependence | Opioid Dependence

United States
University of Texas Southwestern Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Exercise as a Treatment for Substance Use Disorders Protocol (STRIDE)

Stimulant Abuse and Dependence

United States
Yale University

Completed

Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET

Cocaine Dependence | Opiate Dependence

United States
Icahn School of Medicine at Mount Sinai
National Institute on Drug Abuse (NIDA)

Terminated

A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation

Nicotine Addiction

United States
National Institute on Drug Abuse (NIDA)

Completed

Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence

Methamphetamine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Effects of Brief Training on Craving Regulation

Nicotine Addiction

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Effects of E-cigarette Flavors on Youth TCORS 2.0

Nicotine Use Disorder

United States
University of California, Los Angeles

Completed

Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1

Heroin Dependence | Substance Withdrawal Syndrome | Morphine Dependence

United States
Rutgers, The State University of New Jersey

Recruiting

Identify the Optimal TMS Target to Modulate Reward Activity

Nicotine Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Effects of E-Cigarette Flavors on Adults TCORS 2.0

Nicotine Use Disorder

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14

Substance-Related Disorders | Opioid Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

FMRI of Stress and Addictive Disorders

Alcoholism | Opioid Dependence | Cocaine Dependence | Adolescents | Pathological Gamblers

United States
Yale University
National Institute on Drug Abuse (NIDA); National Center for Advancing Translational...

Completed

Acute Effects of Vaping Nicotine on Cognition in Young Adults

Vaping | Nicotine Addiction

United States
Stony Brook University

Unknown

Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings

Cigarette Smoking | Nicotine Addiction

United States
Catalyst Pharmaceuticals, Inc.

Terminated

Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence

Methamphetamine Dependence

United States
Beth Israel Medical Center
AstraZeneca

Terminated

Anxiety in Recovering Opiate Dependence

Generalized Anxiety Disorder | Comorbid Opiate Dependence in Remission | Status Post Methadone-Maintenance Treatment

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse

Cocaine Dependent | Alcohol Dependent

United States
Yale University
National Institute on Drug Abuse (NIDA)

Recruiting

Sex Differences in E-cig Perception: Study 1

Cigarette Smoking | Sex Differences | Nicotine Addiction | E-Cig Use

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Effects of Transcranial Direct Current Stimulation on Tobacco Withdrawal Symptoms (tDCSsmokers)

Nicotine Withdrawal | Tobacco Abstinence

United States
University of California, Los Angeles

Completed

Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1

Heroin Dependence | Substance Withdrawal Syndrome | Morphine Dependence

United States
NYU Langone Health
University of New Mexico; Heffter Research Institute

Completed

A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence

Alcohol Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Active, not recruiting

CB1R in Synthetic Psychoactive Cannabinoids (CB1R in Spice)

Drug Dependence

United States
New York State Psychiatric Institute

Completed

Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence

Cannabis Dependence

United States
NYU Langone Health

Active, not recruiting

Electronic Cigarettes as a Harm Reduction Strategy Among People Living With HIV/AIDS

Nicotine Addiction

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Study of Quetiapine Treatment for Cannabis Dependence (STUC)

Cannabis Dependence

United States
New York State Psychiatric Institute

Completed

Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence (GUAN)

Cannabis Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Quetiapine Pharmacotherapy for Cannabis Dependence (QUEST)

Cannabis Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

A Sequenced Behavioral and Medication Intervention for Cocaine Dependence

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Facilitating the Behavioral Treatment of Cannabis Use Disorder

Cannabis Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Terminated

The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence

Cocaine Dependence

United States
New York State Psychiatric Institute

Completed

Glutamatergic Modulation of Cocaine-related Deficits

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence (Vyvance)

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effect of Baclofen on Marijuana Withdrawal and Relapse

Marijuana Dependence

United States
New York State Psychiatric Institute
Novel Cocaine Pharmacotherapies

Terminated

Effects of Vigabatrin on Cocaine Self-Administration

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Progesterone Treatment for Cocaine-dependent Women: A Pilot Study (PROG)

Cocaine Dependence

United States

Clinical Trials on Nicotine Dependence in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations